New perspectives on the treatment of metastatic renal cell carcinoma: an introduction and historical overview.

The oncologist

Volumn 16 Suppl 2, Issue , 2011, Pages 1-3

  Motzer, Robert J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CLINICAL TRIAL (TOPIC); COST BENEFIT ANALYSIS; EDITORIAL; HUMAN; KIDNEY CARCINOMA; KIDNEY TUMOR; METASTASIS; PATHOLOGY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, RENAL CELL; CLINICAL TRIALS AS TOPIC; COST-BENEFIT ANALYSIS; HUMANS; KIDNEY NEOPLASMS; NEOPLASM METASTASIS;

EID: 79955812355     PISSN: None     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2011-S2-01     Document Type: Editorial

References (0)